-
Real-world comparison of daratumumab-based regimens in relapsed/refractory multiple myeloma using health record data
Benjamin A. Derman et al.,
Blood Neoplasia, 2024
-
Clinical trial is enrolling patients with CML. Find enrolling ASC2ESCALATE clinical trial information today.
Sponsored by Novartis Pharmaceuticals Corporation
-
The ASC2ESCALATE clinical trial is now enrolling for patients with CML. Find enrolling information today.
Sponsored by Novartis Pharmaceuticals Corporation
-
Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy
Thomas F. Siegert et al.,
Blood VTH, 2024
-
Water reuse in Brazilian rice farming: Application of semiquantitative microbiological risk assessment
Maíra Araújo de Mendonça Lima et al.,
Water Cycle, 2022